首页> 外国专利> Methods for treating nuclear factor kappa-light-chain-enhancer of activated B cell (NF-κB) dysregulation in a host in need thereof using eggshell membrane compositions

Methods for treating nuclear factor kappa-light-chain-enhancer of activated B cell (NF-κB) dysregulation in a host in need thereof using eggshell membrane compositions

机译:使用蛋壳膜组合物治疗有需要的宿主中活化的B细胞核因子κ轻链增强子(NF-κB)失调的方法

摘要

The present invention relates to the use of eggshell membrane compositions to activate levels of nuclear factor kappa-light-chain-enhancer of activated B cells (“NF-κB”) in the gut of a host in need thereof and methods of treating conditions related to NF-KB dysregulation. The herein invention provides a method for activating NF-κB in the gut of a host in need thereof. The method comprises orally administering an effective amount of a composition consisting essentially of eggshell membrane, and/or eggshell membrane isolates and/or eggshell membrane hydrolysates for activation of NF-κB to the host.
机译:本发明涉及蛋壳膜组合物在需要其的宿主的肠中激活被激活的B细胞的核因子κ轻链增强子(“NF-κB”)水平的用途以及治疗相关疾病的方法NF-KB失调。本发明提供了一种在需要其的宿主的肠中激活NF-κB的方法。该方法包括口服施用有效量的基本上由蛋壳膜和/或蛋壳膜分离物和/或蛋壳膜水解产物组成的组合物,以将NF-κB活化至宿主。

著录项

  • 公开/公告号US10328104B2

    专利类型

  • 公开/公告日2019-06-25

    原文格式PDF

  • 申请/专利权人 ESM TECHNOLOGIES LLC;

    申请/专利号US201515528335

  • 发明设计人 KEVIN J. RUFF;

    申请日2015-10-08

  • 分类号A61K35/57;A61K38/43;A61K35/741;A61P29;A61P37/06;A61P35;A61K45/06;

  • 国家 US

  • 入库时间 2022-08-21 12:16:00

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号